Tumor derived mutations of protein tyrosine phosphatase receptor type k affect its function and alter sensitivity to chemotherapeutics in glioma.

by Supreet Agarwal, Maha S Al-Keilani, Mohammad A Y Alqudah, Zita A Sibenaller, Timothy C Ryken, Mahfoud Assem
Published 2013-01-01

NOTCH3 is a prognostic factor that promotes glioma cell proliferation, migration and invasion via activation of CCND1 and EGFR.

by Mohammad A Y Alqudah, Supreet Agarwal, Maha S Al-Keilani, Zita A Sibenaller, Timothy C Ryken, Mahfoud Assem
Published 2013-01-01

Redox active metals and H2O2 mediate the increased efficacy of pharmacological ascorbate in combination with gemcitabine or radiation in pre-clinical sarcoma models

by Joshua D. Schoenfeld, Zita A. Sibenaller, Kranti A. Mapuskar, Megan D. Bradley, Brett A. Wagner, Garry R. Buettner, Varun Monga, Mohammed Milhem, Douglas R. Spitz, Bryan G. Allen
Published 2018-04-01

Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism

by Bryan G. Allen, Sudershan K. Bhatia, Carryn M. Anderson, Julie M. Eichenberger-Gilmore, Zita A. Sibenaller, Kranti A. Mapuskar, Joshua D. Schoenfeld, John M. Buatti, Douglas R. Spitz, Melissa A. Fath
Published 2014-01-01